Hans‐Henning Flechtner

Author

European Organisation for Research and Treatment of Cancer ORCID

Also Known As

B Reeve, Charles S. Cleeland, F Martinelli, Flechtner, H, Flechtner, H., Flechtner, Henning, H Flechtner, H Görgen, H. FLECHTNER, H. Flechtner

219

Publications

21.5K

Citations

H-Index

Concepts

All Affiliations

European Organisation for Research and Treatment of Cancer University Hospital Magdeburg Otto-von-Guericke University Magdeburg The University of Sydney University of Leeds

About

Hans‐Henning Flechtner is an author at European Organisation for Research and Treatment of Cancer specializing in medicine, oncology, and cancer research.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	19	24	1.6K
2	Health Sciences	10	10	638
3	Social Sciences	4	4	210
4	Public Health	1	1	29
5	Child Development	1	1	61

Hans‐Henning Flechtner

Publications

19.2K

Citations

H-Index

Page 1

	Year	Citations
The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International Clinical Trials in Oncology N.K. Aaronson, Sam H. Ahmedzai, Bengt Bergman, JNCI Journal of the National Cancer Institute	1993	15.4K
Patient Self-Reports of Symptoms and Clinician Ratings as Predictors of Overall Cancer Survival Chantal Quinten, John Maringwa, Carolyn Gotay, JNCI Journal of the National Cancer Institute	2011	224
A global analysis of multitrial data investigating quality of life and symptoms as prognostic factors for survival in different tumor sites Chantal Quinten, Francesca Martinelli, Corneel Coens, Cancer	2013	200
International Psychometric Validation of an EORTC Quality of Life Module Measuring Cancer Related Fatigue (EORTC QLQ-FA12) Joachim Weis, Krzysztof A. Tomaszewski, Eva Hammerlid, JNCI Journal of the National Cancer Institute	2016	174
Current state of quality of life and patient-reported outcomes research Andrew Bottomley, Jaap C. Reijneveld, Michael Koller, European Journal of Cancer	2019	165
Minimal clinically meaningful differences for the EORTC QLQ-C30 and EORTC QLQ-BN20 scales in brain cancer patients John Maringwa, Chantal Quinten, Madeleine King, Annals of Oncology Neuro-oncologyMedicineBrain Cancer PatientsEortc Qlq-bn20 ScalesClinical Neurology	2011	155
Minimally important differences for interpreting EORTC QLQ-C30 change scores over time: A synthesis across 21 clinical trials involving nine different cancer types Jammbe Musoro, Corneel Coens, Mirjam A. G. Sprangers, European Journal of Cancer Important DifferencesMedicineCancer ManagementClinical TrialsDifferent Cancer Types	2023	148
RPLND or Primary Chemotherapy in Clinical Stage IIA&sol;B Nonseminomatous Germ Cell Tumors? R. Bußar-Maatz, Hans‐Henning Flechtner, Uwe Pichlmeier, European Urology UrologySurgical OncologyMedicineSurgical PathologyMetronomic Therapy	2000	142
Fatigue in long-term survivors of Hodgkin‘s lymphoma; a report from the German Hodgkin Lymphoma Study Group (GHSG) Jens Ulrich Rüffer, Hans‐Henning Flechtner, P. Tralls, European Journal of Cancer Lymphoid NeoplasiaFatigue ManagementHodgkin ‘MedicineFatigue	2003	142
The effects of age on health-related quality of life in cancer populations: A pooled analysis of randomized controlled trials using the European Organisation for Research and Treatment of Cancer (EORTC) QLQ-C30 involving 6024 cancer patients Chantal Quinten, Corneel Coens, Irina Ghislain, European Journal of Cancer Quality Of LifeGeriatric OncologyHealth-related QualityLongevityMedicine	2015	141

Page 1